R906, a plasmid derived from a wild strain of Bordetella bronchiseptica, was transferred to Escherichia coli K I~. In this host it is stably heritable, replicating as a DNA molecule with a molecular weight of 34-6 megadaltons. There are approximately three copies of the plasmid per chromosome. It is a member of compatibility group P. In E. coli, R906 confers resistance to ampicillin, streptomycin, sulphonamides and mercury salts. Resistance to ampicillin is determined by an oxacillin-hydrolysing P-lactamase whereas the resistance to streptomycin is not determined by either of the previously described streptomycin-inactivating enzymes but by some other mechanism.
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* A, ampicillin; S, streptomycin; T, tetracycline; C, chloramphenicol; K, kanamycin; Su, sulphonamides;
Tp, trimethoprim ; Gk, gentamicin and kanamycin.
except that protoplasts were prepared by incubation with lysozyme for 10 min at 37 "C before lysis with detergegt.
R E S U L T S
Phenotypic characteristics of R906+ strains of E. coli K12 Bordetella bronchiseptica, strain BOI 6R+, transferred a plasmid, designated R906, to E. coli 553.2. R 906 is presumably identical with Rter6 (Terakado et al. 1973) . In the latter host, R906 conferred resistance to ampicillin, streptomycin, sulphonamides and mercury salts. Strain ~frc(Rgo6) was visibly lysed by MS2 showing that R906 was fi-. R906f strains were visibly lysed by phage PRRI, a sensitivity so far limited to strains carrying plasmids of group P (Olsen & Shipley, 1973; Jobanputra & Datta, 1974; .
R906 was transferred between strains of E. coli K I~ with an efficiency of about 2 x 1 0 -~/ donor/h ( Table 2) .
Molecular properties of R906 The covalently closed circular (c.c.c.) DNA tertiary form of plasmid R906 was isolated by using dye-buoyant density centrifugation, and its molecular weight was determined by comparing its sedimentation rate through a neutral sucrose gradient with bacteriophage h DNA. Figure ~ ( a ) shows the sedimentation of 3H-labelled R906 DNA together with 14C-labelled h DNA. Sedimentation was from right to left. It was proved that the 3H-DNA bands peaking at fractions 14 and 25 were C.C.C. DNA and its open circular (ox.) form respectively, by treating the R906 DNA with a very low concentration of deoxyribonuclease I. This enzyme converts C.C.C. DNA to the O.C. form, and the result of sedimenting the The DNA sample was treated with an equal volume of DNase I (5 x 10-l' g/ml) in 25 mM-MgSO, for 7 min at 25 "C. DNase I activity was stopped by the addition of one volume of 60 mM-Na2 EDTA. Fractions (0.1 ml) were collected directly onto glass-fibre discs and, after drying, washing and re-drying, were assayed for radioactivity. 0 , 3H; 0, 14C. treated DNA is shown in Fig. I (b) . All the DNA previously peaking at fraction 14 (Fig. I a) now peaked at fraction 25. A 3H-DNA band peaking at fraction 2 (Fig. I a) was an artifact since no DNA band corresponding to this band was observed in Fig. I (b) . It was probably formed by concentration of the leading edge of the C.C.C. DNA band at the tube bottom. Only one plasmid species was therefore present in strain w3110~(Rg06). The molecular weight of Rgo6 DNA was calculated to be 34.6 megadaltons, and 3-1 plasmid copies per E. coli chromosome were isolated as C.C.C. DNA. 
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The absolute rate of hydrolysis of benzylpenicillin was 1.9 nmol/min/~o~ R+ bacteria.
Interactions of R906 with other plasmids R906 was tested for compatibility with the representative plasmids of the compatibility groups listed in Table I ., It was compatible with all except the representatives of group P, RP4 and R751. The evidence for incompatibility is presented in Table 2 . Also shown in this Table is the evidence for exclusion of transfer of RP4 by R906 and of the reciprocal transfer.
The frequency of transfer of several P group plasmids has been shown to be inhibited by the presence of an R factor of group Ia in the donor (Datta et al. 1971; . The rate of transfer of R906 is not significantly reduced by the presence of R144 in the donor (Table 2) .
Ampicillin resistance of R906 In E. coli ~1 2 , R906 conferred resistance to low levels ofp-lactam antibiotics (up to 5 ,ug/ml with ampicillin). Cultures of 553(R906) produced low levels of an oxacillin-hydrolysing ,8-lactamase of a type not previously reported ( Table 3) . The substrate specificity profile of this enzyme resembled that determined by R7 and R16, two plasmids of compatibility group 0 , but the R906 p-lactamase hydrolysed cephaloridine more efficiently. The R906 enzyme was completely resistant to inhibition by 0.5 rnM-p-chloromercuribenzoate, but its activity could be inhibited by chloride ions since its activity was reduced to 50 yo by a 50 mM solution of sodium chloride.
Streptomycin resistance of R906
Although the presence of R906 increased the resistance of the strain towards both streptomycin and spectinomycin no enzymic activity modifying either of these antibiotics could be detected (J. Da.vies, personal communication , the U.S.A. ) and the Republic of South Africa (A. van Rensberg, personal communication) . Thus, the finding of a P plasmid in a strain isolated in Japan is further evidence for the worldwide distribution of plasmids of this group. The existence of phages, such as PRRI, which adsorb to pili produced only by bacteria carrying P plasmids (R. H. Olsen, personal communication) is also evidence for the abundance of these plasmids.
The antibiotic resistance mechanisms of R906 were also studied. The plasmid determined very low levels of an oxacillin hydrolysing /I-lactamase, which presumably explains its ability to confer resistance to penicillins. Resistance to streptomycin and spectinomycin is apparently conferred by a mechanism different from that previously described (Davies, Brzezinska & Benveniste, 1971 ) since cultures of 553.2(R906) showed no ability to alter the structure of either antibiotic. Perhaps the presence of R906 reduces the rate of uptake of these drugs.
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